Blutt Mitchell J Md

Avg. Two Year Performance

77% Avg. Purchase Return
33% Compound
(59%) Avg. Sale Return
(26%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return23%37%72%105%77%
Purchase Success Rate4 of 75 of 76 of 73 of 72 of 7
Average Sale Return(12%)(14%)3%(20%)(59%)
Sale Success Rate5 of 86 of 86 of 84 of 81 of 8
Drugs » Biotechnology

Director:

Holdings: 220.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

136% Purchase Return    54% Compound
(67%) Sale Return    (29%) Compound

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--